Country Trust Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-8
Closed -$1K – 415
2022
Q1
$1K Hold
8
– – ﹤0.01% 412
2021
Q4
$1K Sell
8
-5
-38% -$603 ﹤0.01% 496
2021
Q3
$2K Buy
+13
New +$1.67K ﹤0.01% 458
2019
Q1
– Sell
-382
Closed -$27K – 342
2018
Q4
$27K Hold
382
– – ﹤0.01% 183
2018
Q3
$37K Hold
382
– – ﹤0.01% 155
2018
Q2
$36K Hold
382
– – ﹤0.01% 156
2018
Q1
$34K Hold
382
– – ﹤0.01% 165
2017
Q4
$32K Sell
382
-30
-7% -$2.51K ﹤0.01% 159
2017
Q3
$36K Hold
412
– – ﹤0.01% 143
2017
Q2
$32K Hold
412
– – ﹤0.01% 148
2017
Q1
$29K Buy
412
+19
+5% +$1.28K ﹤0.01% 141
2016
Q4
$23K Hold
393
– – ﹤0.01% 162
2016
Q3
$26K Hold
393
– – ﹤0.01% 158
2016
Q2
$21K Hold
393
– – ﹤0.01% 163
2016
Q1
$20K Hold
393
– – ﹤0.01% 160
2015
Q4
$28K Hold
393
– – ﹤0.01% 150
2015
Q3
$24K Sell
393
-2,715
-87% -$214K ﹤0.01% 153
2015
Q2
$261K Buy
3,108
+2,715
+691% +$211K 0.01% 104
2015
Q1
$30K Buy
+393
New +$27.5K ﹤0.01% 151

Other funds holding XBI

Country Trust Bank's XBI Position: Q2 2022 in Review

Country Trust Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 8 shares — an estimated $1K sold.

Country Trust Bank first reported a position in XBI in Q1 2015 and held it in 19 quarters. The position peaked at $261K in Q2 2015. 704 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

  • Country Trust Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
  • Country Trust Bank sold 8 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $1K.
  • Country Trust Bank first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 19 quarters.
  • Country Trust Bank's State Street SPDR S&P Biotech ETF position peaked at $261K in Q2 2015.
  • 704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Country Trust Bank's 13F filing for Q2 2022, filed 12 Jul 2022.